• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于曲奥舒凡及其生物活性环氧化物转化剂稳定性研究的直接高效液相色谱法与折射检测法。

Direct high-performance liquid chromatography method with refractometric detection designed for stability studies of treosulfan and its biologically active epoxy-transformers.

机构信息

Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 6 Święcickiego Street, 60-781 Poznań, Poland.

出版信息

J Pharm Biomed Anal. 2013 Jan;72:145-9. doi: 10.1016/j.jpba.2012.10.005. Epub 2012 Oct 16.

DOI:10.1016/j.jpba.2012.10.005
PMID:23146239
Abstract

Treosulfan (TREO) is an alkylating agent registered for treatment of advanced platin-resistant ovarian carcinoma. Nowadays, TREO is increasingly applied iv in high doses as a promising myeloablative agent with low organ toxicity in children. Under physiological conditions it undergoes pH-dependent transformation into epoxy-transformers (S,S-EBDM and S,S-DEB). The mechanism of this reaction is generally known, but not its kinetic details. In order to investigate kinetics of TREO transformation, HPLC method with refractometric detection for simultaneous determination of the three analytes in one analytical run has been developed for the first time. The samples containing TREO, S,S-EBDM, S,S-DEB and acetaminophen (internal standard) were directly injected onto the reversed phase column. To assure stability of the analytes and obtain their complete resolution, mobile phase composed of acetate buffer pH 4.5 and acetonitrile was applied. The linear range of the calibration curves of TREO, S,S-EBDM and S,S-DEB spanned concentrations of 20-6000, 34-8600 and 50-6000 μM, respectively. Intra- and interday precision and accuracy of the developed method fulfilled analytical criteria. The stability of the analytes in experimental samples was also established. The validated HPLC method was successfully applied to the investigation of the kinetics of TREO activation to S,S-EBDM and S,S-DEB. At pH 7.4 and 37 °C the transformation of TREO followed first-order kinetics with a half-life 1.5h.

摘要

曲奥舒凡(TREO)是一种烷化剂,已注册用于治疗晚期铂类耐药卵巢癌。如今,TREO 越来越多地以高剂量静脉内给药,作为一种有前途的低器官毒性骨髓清除剂在儿童中应用。在生理条件下,它会发生 pH 依赖性转化为环氧化物转化剂(S,S-EBDM 和 S,S-DEB)。该反应的机制通常是已知的,但动力学细节尚不清楚。为了研究 TREO 转化的动力学,首次开发了一种 HPLC 方法,该方法带有折射检测,可在一次分析运行中同时测定三种分析物。将含有 TREO、S,S-EBDM、S,S-DEB 和对乙酰氨基酚(内标)的样品直接注入反相柱。为了确保分析物的稳定性并获得其完全分离,应用了由醋酸盐缓冲液 pH 4.5 和乙腈组成的流动相。TREO、S,S-EBDM 和 S,S-DEB 的校准曲线的线性范围分别为 20-6000、34-8600 和 50-6000 μM。所开发方法的日内和日间精密度和准确度符合分析标准。还确定了实验样品中分析物的稳定性。验证后的 HPLC 方法成功应用于 TREO 向 S,S-EBDM 和 S,S-DEB 转化动力学的研究。在 pH 7.4 和 37°C 下,TREO 的转化遵循一级动力学,半衰期为 1.5 小时。

相似文献

1
Direct high-performance liquid chromatography method with refractometric detection designed for stability studies of treosulfan and its biologically active epoxy-transformers.用于曲奥舒凡及其生物活性环氧化物转化剂稳定性研究的直接高效液相色谱法与折射检测法。
J Pharm Biomed Anal. 2013 Jan;72:145-9. doi: 10.1016/j.jpba.2012.10.005. Epub 2012 Oct 16.
2
Determination of partition coefficients n-octanol/water for treosulfan and its epoxy-transformers: an example of a negative correlation between lipophilicity of unionized compounds and their retention in reversed-phase chromatography.测定曲奥沙仑及其环氧化物转化物的正辛醇/水分配系数:未离解化合物亲脂性与其在反相色谱中保留之间呈负相关的实例。
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Apr 1;923-924:92-7. doi: 10.1016/j.jchromb.2013.02.012. Epub 2013 Feb 19.
3
HPLC method for determination of biologically active epoxy-transformers of treosulfan in human plasma: pharmacokinetic application.高效液相色谱法测定人血浆中具有生物活性的表鬼臼毒环氧转化物:药代动力学应用。
J Pharm Biomed Anal. 2012 Mar 25;62:105-13. doi: 10.1016/j.jpba.2011.12.021. Epub 2011 Dec 24.
4
Rapid and sensitive liquid chromatography-tandem mass spectrometry method for determination of protein-free pro-drug treosulfan and its biologically active monoepoxy-transformer in plasma and brain tissue.用于测定血浆和脑组织中无蛋白前药苏消安及其生物活性单环氧转化产物的快速灵敏液相色谱-串联质谱法
Talanta. 2014 Sep;127:123-32. doi: 10.1016/j.talanta.2014.03.067. Epub 2014 Apr 4.
5
Activation of Prodrug Treosulfan at pH 7.4 and 37°C Accompanied by Hydrolysis of Its Active Epoxides: Kinetic Studies with Clinical Relevance.前体药物曲奥舒凡在pH 7.4和37°C下的活化及其活性环氧化物的水解:具有临床相关性的动力学研究
J Pharm Sci. 2015 Dec;104(12):4433-4442. doi: 10.1002/jps.24662. Epub 2015 Sep 30.
6
Formation Rate-Limited Pharmacokinetics of Biologically Active Epoxy Transformers of Prodrug Treosulfan.前体药物曲奥舒凡生物活性环氧转化物的形成速率限制型药代动力学。
J Pharm Sci. 2016 May;105(5):1790-1797. doi: 10.1016/j.xphs.2016.03.001. Epub 2016 Apr 1.
7
Effect of Temperature on the Kinetics of the Activation of Treosulfan and Hydrolytic Decomposition of Its Active Epoxy Derivatives.温度对曲奥沙仑的动力学活化及其活性环氧衍生物水解分解的影响。
J Pharm Sci. 2017 Oct;106(10):3156-3160. doi: 10.1016/j.xphs.2017.05.033. Epub 2017 Jul 29.
8
Pharmacokinetics of treosulfan and its active monoepoxide in pediatric patients after intravenous infusion of high-dose treosulfan prior to HSCT.在造血干细胞移植前静脉输注高剂量苏消安后,小儿患者体内苏消安及其活性单环氧化物的药代动力学。
Eur J Pharm Sci. 2015 Feb 20;68:87-93. doi: 10.1016/j.ejps.2014.12.010. Epub 2014 Dec 16.
9
Ocular disposition of treosulfan and its active epoxy-transformers following intravenous administration in rabbits.静脉注射后兔体内曲奥舒凡及其活性环氧转化产物的眼部分布情况。
Drug Metab Pharmacokinet. 2016 Oct;31(5):356-362. doi: 10.1016/j.dmpk.2016.07.001. Epub 2016 Jul 14.
10
Determination of treosulfan in plasma and urine by HPLC with refractometric detection; pharmacokinetic studies in children undergoing myeloablative treatment prior to haematopoietic stem cell transplantation.采用示差折光检测的高效液相色谱法测定血浆和尿液中的苏消安;对接受造血干细胞移植前清髓治疗的儿童进行药代动力学研究。
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 May 1;850(1-2):569-74. doi: 10.1016/j.jchromb.2006.12.020. Epub 2006 Dec 22.

引用本文的文献

1
Treosulfan Exposure Predicts Thalassemia-Free Survival in Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Cell Transplantation.硼替佐米治疗多发性骨髓瘤的疗效及安全性评价
Clin Pharmacol Ther. 2024 Jan;115(1):116-125. doi: 10.1002/cpt.3078. Epub 2023 Nov 7.